1. Home
  2. NVCR vs WRD Comparison

NVCR vs WRD Comparison

Compare NVCR & WRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • WRD
  • Stock Information
  • Founded
  • NVCR 2000
  • WRD 2017
  • Country
  • NVCR Switzerland
  • WRD China
  • Employees
  • NVCR N/A
  • WRD N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • WRD
  • Sector
  • NVCR Health Care
  • WRD
  • Exchange
  • NVCR Nasdaq
  • WRD NYSE
  • Market Cap
  • NVCR 1.9B
  • WRD 1.9B
  • IPO Year
  • NVCR 2015
  • WRD 2024
  • Fundamental
  • Price
  • NVCR $17.44
  • WRD $8.27
  • Analyst Decision
  • NVCR Buy
  • WRD Buy
  • Analyst Count
  • NVCR 6
  • WRD 2
  • Target Price
  • NVCR $32.83
  • WRD $22.00
  • AVG Volume (30 Days)
  • NVCR 861.0K
  • WRD 10.2M
  • Earning Date
  • NVCR 04-24-2025
  • WRD 05-21-2025
  • Dividend Yield
  • NVCR N/A
  • WRD N/A
  • EPS Growth
  • NVCR N/A
  • WRD N/A
  • EPS
  • NVCR N/A
  • WRD N/A
  • Revenue
  • NVCR $621,711,000.00
  • WRD $49,476,511.00
  • Revenue This Year
  • NVCR $2.90
  • WRD N/A
  • Revenue Next Year
  • NVCR $10.47
  • WRD $194.65
  • P/E Ratio
  • NVCR N/A
  • WRD N/A
  • Revenue Growth
  • NVCR 18.27
  • WRD N/A
  • 52 Week Low
  • NVCR $14.17
  • WRD $6.03
  • 52 Week High
  • NVCR $34.13
  • WRD $44.00
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 48.61
  • WRD N/A
  • Support Level
  • NVCR $16.19
  • WRD N/A
  • Resistance Level
  • NVCR $18.52
  • WRD N/A
  • Average True Range (ATR)
  • NVCR 0.85
  • WRD 0.00
  • MACD
  • NVCR 0.06
  • WRD 0.00
  • Stochastic Oscillator
  • NVCR 54.82
  • WRD 0.00

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About WRD WERIDE INC. SPON ADS EACH REP 3 CL A ORD SHS

WeRide Inc operates in the autonomous driving industry. The company has developed a universal autonomous driving technology platform that integrates full-stack software algorithms, modularized hardware solutions, and a cloud-based infrastructure platform. The company provides autonomous driving products and services from L2 to L4 vehicles. The products of the company includes Robotaxi, Robobus, Robovan, Robosweeper, and others. The company earns its revenue from the People's Republic of China.

Share on Social Networks: